Hormone sensitive protocol for metastatic prostate cancer, an update

Actas Urol Esp (Engl Ed). 2023 May;47(4):244-249. doi: 10.1016/j.acuroe.2022.10.002. Epub 2022 Oct 18.
[Article in English, Spanish]

Abstract

To review and update last protocols in hormone sensitive metastatic prostate cancer for improving clinical management in routine. Evidence analysis available about recent updates protocols in hormone sensitive metastatic prostate cancer according to expert panel of clinicians about this field. A nominal consensus group for unify and improve the recommendations to the management of sensitive metastatic prostate cancer patients is currently needed. This document unifies and improve the management of patients with hormone sensitive metastatic prostate cancer, with a methodology that combines data quantitative and qualitative and based on the participation of a broad scientific committee appointed by the Spanish Association of Urology.

Keywords: Androgen deprivation therapy; Clinical follow-up; Cáncer de próstata metastásico; Hormone sensitive metastatic prostate cancer; Manejo clínico; Terapia de deprivación de andrógenos; Tratamiento; Treatment.

MeSH terms

  • Androgen Antagonists
  • Hormones
  • Humans
  • Male
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / pathology
  • Urology*

Substances

  • Androgen Antagonists
  • Hormones